Literature DB >> 33553262

Cardiac Mineralocorticoid Receptor and the Na+/H+ Exchanger: Spilling the Beans.

Irene Lucía Ennis1, Néstor Gustavo Pérez1.   

Abstract

Current evidence reveals that cardiac mineralocorticoid receptor (MR) activation following myocardial stretch plays an important physiological role in adapting developed force to sudden changes in hemodynamic conditions. Its underlying mechanism involves a previously unknown nongenomic effect of the MR that triggers redox-mediated Na+/H+ exchanger (NHE1) activation, intracellular Na+ accumulation, and a consequent increase in Ca2+ transient amplitude through reverse Na+/Ca2+ exchange. However, clinical evidence assigns a detrimental role to MR activation in the pathogenesis of severe cardiac diseases such as congestive heart failure. This mini review is meant to present and briefly discuss some recent discoveries about locally triggered cardiac MR signals with the objective of shedding some light on its physiological but potentially pathological consequences in the heart.
Copyright © 2021 Ennis and Pérez.

Entities:  

Keywords:  NHE1; aldosterone; heart failure; mineralocorticoid receptor (MR); myocardial stretch; oxidative stress

Year:  2021        PMID: 33553262      PMCID: PMC7854694          DOI: 10.3389/fcvm.2020.614279

Source DB:  PubMed          Journal:  Front Cardiovasc Med        ISSN: 2297-055X


  54 in total

1.  Stimulation of myocardial Na(+)-independent Cl(-)-HCO(3)(-) exchanger by angiotensin II is mediated by endogenous endothelin.

Authors:  M C de Hurtado; B V Alvarez; I L Ennis; H E Cingolani
Journal:  Circ Res       Date:  2000-03-31       Impact factor: 17.367

Review 2.  Targeting calcium and the mitochondria in prevention of pathology in the heart.

Authors:  Helena M Viola; Livia C Hool
Journal:  Curr Drug Targets       Date:  2011-05       Impact factor: 3.465

3.  Mechanisms underlying the increase in force and Ca(2+) transient that follow stretch of cardiac muscle: a possible explanation of the Anrep effect.

Authors:  B V Alvarez; N G Pérez; I L Ennis; M C Camilión de Hurtado; H E Cingolani
Journal:  Circ Res       Date:  1999-10-15       Impact factor: 17.367

4.  Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.

Authors:  Bertram Pitt; Stefan D Anker; Michael Böhm; Mihai Gheorghiade; Lars Køber; Henry Krum; Aldo P Maggioni; Piotr Ponikowski; Adriaan A Voors; Faiez Zannad; Christina Nowack; So-Young Kim; Alexander Pieper; Nina Kimmeskamp-Kirschbaum; Gerasimos Filippatos
Journal:  Eur J Heart Fail       Date:  2015-02       Impact factor: 15.534

5.  Mineralocorticoid receptor activation is crucial in the signalling pathway leading to the Anrep effect.

Authors:  Claudia I Caldiz; Romina G Díaz; Mariela B Nolly; Gladys E Chiappe de Cingolani; Irene L Ennis; Horacio E Cingolani; Néstor G Pérez
Journal:  J Physiol       Date:  2011-12-15       Impact factor: 5.182

6.  Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src.

Authors:  Glaucia E Callera; Rhian M Touyz; Rita C Tostes; Alvaro Yogi; Ying He; Sam Malkinson; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

7.  Influence of Na+-independent Cl--HCO3- exchange on the slow force response to myocardial stretch.

Authors:  Horacio E Cingolani; Gladys E Chiappe; Irene L Ennis; Patricio G Morgan; Bernardo V Alvarez; Joseph R Casey; Raúl A Dulce; Néstor G Pérez; María C Camilión de Hurtado
Journal:  Circ Res       Date:  2003-10-23       Impact factor: 17.367

8.  EF domains are sufficient for nongenomic mineralocorticoid receptor actions.

Authors:  Claudia Grossmann; Ruth Freudinger; Sigrid Mildenberger; Britta Husse; Michael Gekle
Journal:  J Biol Chem       Date:  2008-01-08       Impact factor: 5.157

9.  Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Authors:  S Kato; H Endoh; Y Masuhiro; T Kitamoto; S Uchiyama; H Sasaki; S Masushige; Y Gotoh; E Nishida; H Kawashima; D Metzger; P Chambon
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

10.  A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.

Authors:  Gerasimos Filippatos; Stefan D Anker; Michael Böhm; Mihai Gheorghiade; Lars Køber; Henry Krum; Aldo P Maggioni; Piotr Ponikowski; Adriaan A Voors; Faiez Zannad; So-Young Kim; Christina Nowack; Giovanni Palombo; Peter Kolkhof; Nina Kimmeskamp-Kirschbaum; Alexander Pieper; Bertram Pitt
Journal:  Eur Heart J       Date:  2016-04-29       Impact factor: 35.855

View more
  1 in total

Review 1.  The expanding class of mineralocorticoid receptor modulators: New ligands for kidney, cardiac, vascular, systemic and behavioral selective actions.

Authors:  E Bădilă
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.